CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Grant or award Director acquired 8,367 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale EVP, Research and Development sold 43,451 shares at $50.35 ($2,187,758)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Commercial sold 32,110 shares at $49.81 ($1,599,399)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President and CEO gave up 128,497 shares (to pay taxes)
- 4 Open-market sale EVP and CFO sold 34,901 shares at $50.00 ($1,745,050)
- 4 Shares withheld for taxes EVP, Commercial gave up 33,265 shares (to pay taxes)
- 4 Planned sale SVP and General Counsel sold 6,625 shares at $50.21 ($332,641)
- 4 Shares withheld for taxes EVP, Research and Development gave up 30,578 shares (to pay taxes)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 2 of 126 · 2,517 filings